STIPE Therapeutics ApS: Financial statements 2021
CVR: 39691175
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
STIPE Therapeutics ApS (CVR 39691175) has filed annual accounts for 2021. In 2021, the company reported a gross profit of EUR -4,086,580 and a net result of EUR -5,485,392 compared with EUR -3,867,652 the year before. Equity in the 2021 report amounted to EUR 10,231,888. The solvency ratio was 70.5%. The company had 16 employees in the financial year.
- Gross Profit
- EUR -4,086,580
- Profit/Loss
- EUR -5,485,392
- Equity
- EUR 10,231,888
- Total Assets
- EUR 14,511,480
- Employees
- 16
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -4.1 mio. EUR | -5.5 mio. EUR | 10.2 mio. EUR | 16 |
| 2020 | - | -2.9 mio. EUR | -3.9 mio. EUR | 3.8 mio. EUR | 14 |
Official annual report
Find more companies like STIPE Therapeutics ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
As of December 2, 2021, CLAUS OLESEN HOLDING ApS is registered as an owner of STIPE Therapeutics ApS with an ownership share of 5%.
As of December 2, 2021, MR Jakobsen Holding ApS is registered as an owner of STIPE Therapeutics ApS with an ownership share of 10%.
As of July 31, 2021, Martin Roelsgaard Jakobsen has stepped down as director of STIPE Therapeutics ApS.
As of July 6, 2021, Mark David Chin has joined the board of directors of STIPE Therapeutics ApS.
As of July 6, 2021, John Stephen Cassidy has left the board of directors of STIPE Therapeutics ApS.
STIPE Therapeutics ApS has published its annual report for 2020. Gross profit came to DKK -2,948,722, and the net result was DKK -3,867,652.
As of April 29, 2021, EY Godkendt Revisionspartnerselskab has been appointed auditor of STIPE Therapeutics ApS.
As of February 1, 2021, John Stephen Cassidy has joined the board of directors of STIPE Therapeutics ApS.
As of January 31, 2021, Jonathan Leslie Tobin has left the board of directors of STIPE Therapeutics ApS.
About STIPE Therapeutics ApS
STIPE Therapeutics ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2018. The company is under bankruptcy. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company's owners include CLAUS OLESEN HOLDING ApS, Novo Holdings A/S and Sunstone Life Science Ventures Fund IV K/S. The company has 1 employee (2024). In 2024, the company reported a gross profit of EUR -842,285 and a net result of EUR 1,448,748 compared with EUR -4,456,130 the year before. Equity in the 2024 report amounted to EUR 1,087,512.